Medicare quietly opens accreditation gate for vulnerable beneficiaries
H.R. 6974 — Improving MA SNP Act of 2026 · Filed by Jodey Arrington (R-TX) · Introduced Jan 8, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands which organizations can accredit specialized Medicare Advantage plans (SNPs) that serve people with specific chronic conditions or disabilities. Currently, only NCQA (National Committee for Quality Assurance) can approve these plans. The bill allows other private accrediting organizations to do so starting in 2026, provided the Secretary of Health and Human Services approves their application and determines them appropriate.
Why we flagged it
The bill removes a regulatory monopoly (NCQA-only accreditation) and substitutes a Secretary-discretionary approval pathway for competing private accreditors. This is a classic deregulation move: it opens a gated market to new entrants, but does so under a vague 'appropriateness' standard rather than explicit equivalence criteria.
What the text implies
- The bill does not require new accreditors to meet NCQA's specific standards, only that the Secretary find them 'appropriate.' This creates regulatory arbitrage risk: accreditors competing on cost or speed rather than rigor could gain market share, potentially lowering SNP plan quality for vulnerable beneficiaries.
- SNP plans serve dual-eligible (Medicare-Medicaid), institutionalized, and severely disabled populations. Accreditation directly affects plan approval speed and quality gates. Weakening accreditation standards may accelerate plan launches but could expose high-need populations to plans with inadequate care coordination or network adequacy.
- The bill does not specify what 'appropriateness' means or require the Secretary to publish accreditor comparison data. Beneficiaries and providers may lack transparency about which accreditor approved which plan, making quality comparison difficult.
- Existing NCQA accreditation creates a revenue stream for NCQA. New competitors may undercut NCQA's pricing, potentially reducing NCQA's resources for accreditation rigor—a classic market-entry dynamic that can degrade incumbent quality.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Potential benefit: more accreditors may accelerate SNP plan approvals and increase plan options for beneficiaries with chronic conditions. Potential cost: reduced accreditation rigor if new accreditors apply weaker standards; SNP plans serve vulnerable populations (dual-eligible, institutionalized, severely disabled), and quality degradation could harm them. The bill conditions approval on Secretary determination of 'appropriateness' but does not define that standard or require equivalence to NC
Who stands to gain
- private accrediting organizations (new market entrants)
- Medicare Advantage insurers (faster plan approvals, lower accreditation costs)
- health plan consultants and compliance vendors
Named in the bill
NCQA (National Committee for Quality Assurance), HHS Secretary, Medicare Advantage SNP plans, Social Security Act Section 1859(f)(7), Social Security Act Section 1852(e)(4)(C)
Where it stands
- Jan 8, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jan 8, 2026 — Referred to House Committee on Energy and Commerce and House Committee on Ways and Means · Congress.gov: “Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
2 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $150,000 in lobbying spend. A filing names 3 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 41% of bills with at least one filing.
Jodey Arrington, the sponsor, reported $573,000 in PAC receipts in the 2026 cycle.
- Urac — $130,000 on 1 filing
- Utah Associated Municipal Power Systems — $20,000 on 1 filing
Lobbying Disclosure Act filings through Jul 8, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (651 characters) on Jun 8, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 8, 2026 · page rendered 2026-10-20.
“Medicare quietly opens accreditation gate for vulnerable beneficiaries” QuorumCivic. https://share.quorumcivic.app/bill/119/hr6974 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.